SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Funds and ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.
Equities
2196
CNE100001M79
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.54 HKD | +0.15% |
|
+0.59% | -20.35% |
| May. 15 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
| May. 15 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
ETFs positioned on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.37% | 4 M€ | -27.92% | ||
| 0.63% | 2 M€ | -13.00% | - | |
| 0.21% | 3 M€ | +9.08% | - | |
| 0.18% | 2 M€ | -14.14% | ||
| 0.16% | 4 M€ | -11.56% | ||
| 0.03% | 35 M€ | -5.85% | - | |
| 0.02% | 454 M€ | +9.82% | - | |
| 0.02% | 2,867 M€ | +11.13% | - | |
| 0.02% | 153 M€ | +9.25% | - | |
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 32 M€ | +9.19% | - | |
| 0.01% | 112 M€ | +5.31% | - | |
| 0.00% | 34 M€ | +9.12% | - | |
| 0.00% | 34 M€ | +4.49% | - | |
| 0.00% | 39 M€ | +6.43% | - | |
| 0.00% | 306 M€ | +6.54% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 17 M€ | +3.40% | - | |
| 0.00% | 15 M€ | +20.79% | ||
| 0.00% | 7 M€ | +6.59% | - | |
| 0.00% | 8 M€ | +1.17% | - |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.81
CNY
Average target price
28.61
CNY
Spread / Average Target
+20.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock
- Funds and ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
